May 7, 2020
On March 24, 2020, the U.S. Food and Drug Administration (FDA) alerted patients, caregivers, and providers that EpiPen 0.3mg and EpiPen Jr. 0.15mg auto-injectors, and the authorized generic versions, may potentially have a delayed injection or aren’t properly injecting for various documented reasons. The affected EpiPens are manufactured by Mylan.
Patients are asked to contact Mylan customer relations if they find an issue with their auto-injector to receive a replacement at no additional cost.
Dispensing pharmacists should inspect the products at the point of care to ensure quick access to the auto-injector and shouldn’t dispense any product that doesn’t easily slide out of its carrier tube or has a raised blue safety release.
For more information about the errors or other malfunctions with these EpiPens, read the FDA announcement. For questions, email provider.relationswest@premera.com